생화학분자생물학회입니다.
The Complex Role of Extracellular Vesicles in HIV infection
작성자
Jung-Hyun Lee작성일자
2023-07-20조회수
1466![]() |
Name: Jung-Hyun Lee ( jhlee1@uos.ac.kr ) | |
2022-present | Assistant Professor , Department of Life Science, University of Seoul | |
2021-2022 | Project leader, Institute of Molecular Virology, Ulm University, Germany | |
2020-2020 | Research assistant Professor, Florida Research and Innovation, Cleveland Clinic, USA | |
2018-2020 | Postdoctoral scholar, Department of Microbiology, The University of Chicago, USA | |
2016-2018 | Junior group leader, Department of Dermatology, University Hospital of Erlangen, Germany | |
2014-2018 | Postdoctoral fellow, Department of Dermatology, University Hospital of Erlangen, Germany | |
2014 | Ph.D., Molecular virology and Cancer biology, Friedrich-Alexander-University Erlangen-Nürnberg, Germany |
The Complex Role of Extracellular Vesicles in HIV infection
All cells release membrane vesicles called as extracellular vesicles (EVs) during normal physiological and abnormal pathophysiological conditions. Growing evidence has revealed the EVs as an important messenger in intercellular communication. EVs have emerging roles in cellular responses and modulation of immune responses during virus infection. EVs contribute to trigger antiviral responses to restrict virus infection and replication. On the other hand, the role of EVs in facilitation of virus spread and pathogenesis has been widely documented. Depending on the cell of origin, EVs carry effector functions from one cell to the other by horizontal transfer of their bioactive cargos, including DNA, RNA, proteins, lipids, and metabolites. The diverse constituents of EVs can reflect the altered states of cells or tissues during virus infection, thereby offering a diagnostic readout. The exchanges of cellular and/or viral components by EVs can inform their therapeutic potential of EVs for infectious diseases. This review provides recent advances of EVs to explore the complex roles of EVs during virus infection and the therapeutic potential, focusing on HIV-1.
BMB Rep. 2023 Jun;56(6):335-340. doi: 10.5483/BMBRep.2023-0073.
https://pubmed.ncbi.nlm.nih.gov/37291055/